Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 705 citations

Unrelated Donors, Graft-versus-host Disease, Transplantation +12

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke et al. · New England Journal of Medicine · 2016 · 541 citations · Full text

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Andrea Bacigalupo, Teresa Lamparelli, Paolo Bruzzi et al. · Blood · 2001 · 521 citations · Full text

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Irwin Walker, Tony Panzarella, Stephen Couban et al. · The Lancet Oncology · 2015 · 354 citations

Unrelated Donors, Anti-thymocyte Globulin, Transplantation +9

Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation

Andrea Bacigalupo, Teresa Lamparelli, Giovanni Barisione et al. · Biology of Blood and Marrow Transplantation · 2006 · 339 citations · Full text

Late Transplant-related Mortality, Chronic Lung Dysfunction, Transplantation +13